Evaluation of Reduced-Dose Induction Agents During Endotracheal Intubation in Critical Care Transport.
Air Medical Journal · 2024-12-07 · Observational study
Abstract
OBJECTIVE: Induction agent selection and dose are potentially modifiable risk factors to mitigate postintubation hypotension and hemodynamic collapse. Despite it being a common practice, minimal literature exists to support induction agent dose reduction. Our objective was to evaluate the rate of postintubation hemodynamic collapse with reduced-dose compared to full dose induction agents. METHODS: This is a retrospective chart review of adult patients who were endotracheally intubated by a critical care transport team and received etomidate or ketamine for induction. The primary outcome was association of reduced-dose induction agent use (etomidate <0.2 mg/kg or ketamine <1 mg/kg) with postintubation hemodynamic collapse. RESULTS: A total of 304 patients were included; 187 (61.5%) received etomidate and 117 (38.5%) received ketamine. Of these 304 patients, 64 (21.1%) received reduced-dose agents and 240 (78.9%) received full-dose agents. The initial systolic blood pressure and mean arterial blood pressure levels were lower in the reduced-dose arm. Shock index, hemodynamic collapse, and life-threatening hemodynamic collapse did not differ between the groups. CONCLUSION: In this analysis, there was no difference in rates of postintubation hemodynamic collapse with reduced-dose induction agents when compared with full-dose agents.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Critical care & advanced paramedics · Anaesthetics · Etomidate · Interfacility & critical care transport · Endotracheal intubation · Ketamine
Related articles
- Practice Patterns and Performance of Pediatric Air Medical Tracheal Intubation: A National Multisite Cohort Study. (Prehosp Emerg Care, 2026)
- Postintubation Sedation After a Formulary Change From Succinylcholine to Rocuronium in a Critical Care Transport Organization. (Air Med J, 2022)
- Induction Agents for Tracheal Intubation of Critically Ill Patients: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. (Chest, 2026)
- Ketamine/propofol admixture vs etomidate for intubation in the critically ill: KEEP PACE Randomized clinical trial. (J Trauma Acute Care Surg, 2019)
- Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. (Lancet, 2009)
- The effect of etomidate on airway management practices of an air medical transport service. (Prehosp Emerg Care, 2004)